Added to YB: 2024-09-21
Pitch date: 2024-09-21
INMB [bullish]
INmune Bio, Inc.
-62.22%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
INmune Bio, Inc., a clinical-stage immunology company, focuses on developing drugs to reprogram the patients innate immune system to treat disease in the United States.
Market Cap
$50.5M
Pitch Price
$5.32
Price Target
N/A
Dividend
N/A
EV/EBITDA
-0.44
P/E
-0.76
EV/Sales
351.78
Sector
Biotechnology
Category
N/A
Show full summary:
INMUNE BIO INC INMB
A summary for this pitch has not been created yet.
Read full article (0 min)